NCT07227480Recruiting
Advancing Lung Cancer Screening One Text at a Time
Source: ClinicalTrials.gov · Last updated 19 Feb 2026
Brief summary (registry, in English)
The purpose of this study is to assess the feasibility, acceptability, and preliminary impact of text messaging to promote lung cancer screening.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 10 Nov 2025
- Start date
- Feb 2026
- Primary completion date
- Aug 2026
- Lead sponsor
- University of Rochester
- Diseases
- Lung cancer
- NCT number
- NCT07227480
What you commit to
- Study type: Interventional
- Planned participants: 40
- From Feb 2026 to the primary completion date, Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- being up-to-date on their annual lung cancer screening
Who the study is looking for
- 50 to 80 years old
- have not completed their annual screening for lung cancer
- have a 20 pack-year smoking history
- currently smoke or have quit within the past 15 years
- speak English and/or Spanish
- have a functioning cellphone number with unlimited text messaging capacity
- be willing to complete a baseline and a follow-up (at Month 3) survey
Age in the registry: 50 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Rochester Medical Center Coordinator of this site? Confirm its status | Rochester | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.